The Deposit Beat Masks a Margin Cliff — and the Street Already Priced It In
Q2 reported profit jumped 27.6% YoY, beating guidance on deposits and advances. But the quarter rests on elevated recoveries (₹978 Cr, up 190%), faces NIM compression 5 basis points below guidance, and signals H2 profitability will be materially weaker. The stock's 35% drawdown from ATH reflects what the numbers suggest: execution is steady, but earnings power is normalizing.
₹3,222 Cr
+27.6% YoY
₹978 Cr
+190% YoY, ex-run-rate
~₹12,000 Cr
implies H2 weaker than H1 >₹6,000 Cr
Bank of India's Q2 delivered where it counted: advances grew 20.6% (vs 15–16% guidance), deposits 21.6% (raising prior 13–14% target to 16–17%), and asset quality hit record lows (slippage 0.15%, Gross NPA 1.60%). The reported profit jump to ₹3,222 Cr looks like a victory lap. But beneath the surface, the quarter rests on two props that won't repeat. Non-interest income spiked 24.8% to ₹2,770 Cr, driven by written-off asset recoveries of ₹978 Cr—up 190% from a normalized run-rate. Provisions doubled to ₹1,000+ Cr, front-loading ECL norms that will drag H2 earnings. And the kicker: net interest margin (NIM) compressed 5 basis points to 2.47%, missing the 2.55–2.60% guidance floor due to ₹40,600 Cr FCNR inflows and repo hikes. Management is banking on 6–7 bps recovery in H2 from rate pass-through, but that's timing-dependent and unguaranteed.
The math on reported profit
Operating profit delivered strong 33.2% YoY growth to ₹5,089 Cr, signaling management's control on costs and credit origination. But the headline PAT benefit is inflated: exclude the ₹978 Cr recovery spike (a 190% YoY jump unlikely to persist) and provisions normalized, and adjusted profit looks closer to ₹2,600–2,700 Cr—still growing, but at a 12–15% organic clip, not 27.6%. This is not a management red flag; rather, a reminder that the reported number is noisy.
Deposits and advances: management's own claim, now on trial
Advances growth beat 15–16% guidance
Global 20.58% YoY, domestic 17.84%
Supported; 400+ bps beat signals robust credit demand
Deposits raised from 13–14% to 16–17% guidance
Global 21.59% YoY, domestic 23.29%
Supported; actual beat new target too, but CASA ratio diluted to 34.16%
NIM compression is FCNR-driven, temporary
2.47% vs 2.55–2.60% guidance; FCNR $2.2B = ~₹40,600 Cr
Supported but incomplete; recovery to guidance unproven, dependent on repo pass-through lag
Asset quality at multi-year highs
Slippage 0.15% (record low), Gross NPA 1.60% (−94 bps YoY), PCR 94.45%
Supported; best-in-class origination and provisioning discipline
The growth narrative is genuine. A credit pipeline of ₹86,000–87,000 Cr (roughly 10% of the loan book) across corporate (₹65,000 Cr), RAM (₹20,000 Cr), and digital (₹3,000 Cr) segments de-risks concentration and supports the 15–16% FY27 guidance—which management maintained despite the 20.6% beat, a disciplined hold. The deposit surge is equally real: ₹21.6% growth reflects franchise strength and CASA in absolute rupee terms up ₹20,000 Cr (even if the ₹10.37 L Cr total now includes heavier bulk and FCNR mix). But here's the trap: the deposit narrative masks a profitability trap. Growing bulk deposits (lower yielding) and raising ₹2.2 Bn in FCNR (competing for global rates) to fund a rupee credit book under repo pressure is a negative-carry arbitrage. Management is gambling on deposit repricing (they cite 60% with 1–18 month tenor) to offset this, but that depends on timing. If rate hikes accelerate past their 6–7 bps H2 recovery assumption, NIM will remain underwater.
What changed on this call
Deposit guidance raised (13–14% → 16–17%)
Advances guidance maintained (15–16%) despite 20.6% beat
NIM guidance reset lower (2.70–2.75% → 2.55–2.60%) and now at 2.47%
ROA >1% for 3 consecutive quarters; guidance reaffirmed >1% for FY27
FY27 profit guidance ~₹12,000 Cr implies H2 will be ~₹5,800–6,000 Cr (weaker than H1)
The deposit guidance raise is material and reflects genuine acceleration in franchise stickiness. But it comes paired with a NIM reset—management cut the floor from 2.70–2.75% to 2.55–2.60% in Q1, and now sits at 2.47%, signaling that margin recovery is neither imminent nor assured. The profit guidance update (₹12,000 Cr full year) is the subtext: if H1 generated >₹6,000 Cr, then H2 is expected to produce roughly ₹5,800–6,000 Cr—a slowdown of 3–5% QoQ despite two more quarters to deploy the credit pipeline. That slowdown points to ECL front-loading (₹500–600 Cr expected in Q3/Q4) and margin headwinds absorbing the growth upside.
The street's verdict — and why it's ahead of the story
Bank of India's stock has fallen 35.14% from its all-time high to ₹135.7 and now trades below both the 50-day (₹137.53) and 200-day (₹143.9) moving averages—a textbook bearish setup. The Q2 beat did not hold the price. FII ownership ticked down to 6.87% from 7.26% prior quarter; DII flat at 13.96%. Promoter ownership remains locked at 73.38%, a fortress structure but one that has failed to defend the stock's downside. The drawdown looks like it is not about the quarter itself, but about what the numbers imply: a bank in a margin squeeze, growing deposits and loans at healthy pace but sacrificing NIM to do so, and facing ECL headwinds that will suppress H2 profitability. The market has already repriced for this scenario—the fundamental beat is now priced, and the stock's weakness reflects doubt about whether NIM recovery actually happens, or whether 2.47% becomes the new normal.
The bull-bear ledger
Asset quality is best-in-class (slippage 0.15%, PCR 94.45%); fortress balance-sheet with CRAR 17.78%
Deposit franchise genuinely accelerating (21.6% YoY growth); balance-sheet expansion is real
Advances beat 20.6% vs guidance; credit pipeline Rs. 86K Cr provides 9-month cushion
ROA >1% for 3 qtrs; reaffirmed for full year; profitability normalization underway
Management execution credible (beat on growth, transparent on headwinds); tone confident but measured
NIM compressed 5 bps to 2.47% (below 2.55–2.60% guidance); recovery assumed at 6–7 bps but timing unproven
Reported PAT includes ₹978 Cr recovery spike (+190% YoY); sustainable organic growth ~12–15%, not 27.6%
Provisions doubled to ₹1,000+ Cr; ECL front-loading from Q3 will suppress H2 earnings by ~₹500–600 Cr
FY27 guidance implies H2 profitability weaker than H1; macro headwinds (inflation, rate hike risk, geopolitics) unresolved
Stock down 35% from ATH, trading below key averages; FII/DII passive on the beat; market pricing in earnings ceiling
Ranked risks (how much they should concern a holder)
NIM recovery stalls; rate hikes accelerate beyond 6–7 bps assumption
HighIf NIM stays at 2.47% vs 2.55–2.60% guidance, annualized NII shortfall ~₹150–200 Cr (4–5% of PAT). Each 25 bps additional rate hike could shave another 5–8 bps off margins.
ECL front-loading larger than ₹500–600 Cr H2 guidance; capital impact exceeds proforma
MediumCould suppress FY27 PAT guidance; CRAR dips closer to 16%+ (still comfortable but eats growth cushion). Confidence in FY28 ROA >1% questioned.
FCNR deposit outflows accelerate; funding cost spiked; NIM surprise widened downside
Medium₹2.2 Bn ($40,600 Cr) FCNR is volatile. If 25% outflows occur, replacement from higher-cost bulk rupee deposits could imply +10 bps liability cost, forcing equivalent asset-side repricing (or margin sacrifice).
Macro recession (inflation, rate hikes, geopolitics); credit demand moderates; slippage rises
MediumCredit pipeline ₹86K Cr deployment slows; advances growth drops to 12–14% in H2 (vs 20.6% Q2). Slippage uptick from 0.15% to 0.25–0.30% could push Gross NPA above 1.75%, eroding confidence in asset quality narrative.
Infra lending refinancing churn; lower-rate competition absorbs pipeline
Low–MediumManagement flagged COD projects being refinanced at lower rates elsewhere. If pipeline absorption slips <75%, advances growth guidance at risk; margin compression deepens.
Gold loan stress bleeds into Bank of India; NPA spikes from 0.13% to 0.50%+
Low₹61,000 Cr book is insulated (75% LTV, daily CBS monitoring), but NBFC spillover could surprise. Unlikely but low-conviction risk.
The debate
What to watch next (resolve the debate by end-H2)
1 · Deposit repricing lag and repo pass-through (Q3 update)
Management expects 6–7 bps NIM recovery in H2 from repo hike pass-through to deposits (60% have 1–18 month tenor). Watch Q3 for: actual NIM vs guidance, CASA % recovery (is it stabilizing or declining further?), and commentary on repricing pace. If Q3 NIM is still <2.50%, the recovery thesis is at risk.
2 · Organic profit run-rate excluding recoveries and ECL spike (Q3/Q4)
Watch whether normalized non-interest income (ex-recoveries) and standard provisions levels allow BoI to deliver ₹5,800–6,000 Cr in H2 profit, or if ECL front-loading pushes it below ₹5,500 Cr. A shortfall signals the ₹12,000 Cr FY27 guidance is optimistic, raising FY28 visibility concerns.
3 · Credit pipeline deployment and advances guidance momentum (Q3/Q4)
Advances grew 20.6% in Q2 against a 15–16% target. Watch whether ₹86K Cr pipeline is deployed at expected pace or if macro headwinds (inflation, rate hikes, geopolitical risk) slow disbursals. Any slowdown would imply H2 advances growth drops below 18%, putting FY27 guidance at risk and raising questions about FY28 credit growth assumptions.
The takeaway
Bank of India is a steady executor—Q2 beat on the lines that matter (deposits, advances, asset quality), and management's tone reflects confidence, not desperation. But the quarter's reported profit growth (27.6%) is understated when backed out for elevated recoveries and provisions, landing organic growth closer to 12–15%. That steady, not exceptional, performance is now fully priced: the stock is down 35% from ATH and trading below key averages, with FII inflows stalling. The debate has shifted from 'will BoI beat?' (it did) to 'will NIM recover?' and 'is ECL the profit cap?'. Until those questions resolve (likely by Q3 earnings), the stock remains in a wait-and-see posture.
The number to track from here: Q3 NIM. If it stays at or below 2.47%, the 2.55–2.60% guidance is a miss, and the market will reprice downside further. If it reaches 2.51–2.53%, the recovery narrative holds and the stock has upside to ₹150–160. That single metric is the inflection point for the next 6 months.
Informational and educational content only. Not investment advice.